These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 16356399)
1. The role of nitric oxide in the pathogenesis of venous ulcers. Nikolovska S; Pavlova L; Ancevski A; Petrov A; Arsovski A; Dejanova E Acta Dermatovenerol Croat; 2005; 13(4):242-6. PubMed ID: 16356399 [TBL] [Abstract][Full Text] [Related]
2. Deleterious effects of white cells in the course of skin damage in CVI. Coleridge Smith PD Int Angiol; 2002 Jun; 21(2 Suppl 1):26-32. PubMed ID: 12515977 [TBL] [Abstract][Full Text] [Related]
3. The microcirculation in venous hypertension. Smith PD Cardiovasc Res; 1996 Oct; 32(4):789-95. PubMed ID: 8915197 [TBL] [Abstract][Full Text] [Related]
4. [Microcirculatory changes in chronic venous insufficiency]. Matić M; Duran V; Ivkov-Simić M; Poljacki M; Gajinov Z; Begenisić M Med Pregl; 2000; 53(11-12):579-83. PubMed ID: 11320743 [TBL] [Abstract][Full Text] [Related]
5. A potential role of interferon-gamma in the pathogenesis of venous leg ulcers. Simka M Med Hypotheses; 2006; 67(3):639-44. PubMed ID: 16735095 [TBL] [Abstract][Full Text] [Related]
7. Causes and effects of the chronic inflammation in venous leg ulcers. Agren MS; Eaglstein WH; Ferguson MW; Harding KG; Moore K; Saarialho-Kere UK; Schultz GS Acta Derm Venereol Suppl (Stockh); 2000; 210():3-17. PubMed ID: 10884942 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms in chronic venous insufficiency. Bergan J Ann Vasc Surg; 2007 May; 21(3):260-6. PubMed ID: 17484957 [TBL] [Abstract][Full Text] [Related]
9. Valvular density alone cannot account for sites of chronic venous insufficiency and ulceration in the lower extremity. Aharinejad S; Nedwed S; Michlits W; Dunn R; Abraham D; Vernadakis A; Marks SC Microcirculation; 2001 Oct; 8(5):347-54. PubMed ID: 11687946 [TBL] [Abstract][Full Text] [Related]
10. [Venous leg ulcers]. Slagsvold CE; Stranden E Tidsskr Nor Laegeforen; 2005 Apr; 125(7):891-4. PubMed ID: 15815737 [TBL] [Abstract][Full Text] [Related]
11. Direct triggers for ulceration in patients with venous insufficiency. Shai A; Halevy S Int J Dermatol; 2005 Dec; 44(12):1006-9. PubMed ID: 16409265 [TBL] [Abstract][Full Text] [Related]
12. [The trophic venous ulcer. The physiopathological, microbiological and pharmacological aspects]. Trabucchi E; Pace M; Gabrielli L; Annoni F Minerva Cardioangiol; 1994; 42(1-2):43-50. PubMed ID: 8022544 [TBL] [Abstract][Full Text] [Related]
13. Venous leg ulcer treatment and practice--part 1: the causes and diagnosis of venous leg ulcers. Rajendran S; Rigby AJ; Anand SC J Wound Care; 2007 Jan; 16(1):24-6. PubMed ID: 17334142 [TBL] [Abstract][Full Text] [Related]
14. Microcirculation and venous ulcers: a review. Pascarella L; Schönbein GW; Bergan JJ Ann Vasc Surg; 2005 Nov; 19(6):921-7. PubMed ID: 16247708 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of nitric oxide synthase attenuates peroxynitrite generation, but augments neutrophil accumulation in hepatic ischemia-reperfusion in rats. Liu P; Yin K; Nagele R; Wong PY J Pharmacol Exp Ther; 1998 Mar; 284(3):1139-46. PubMed ID: 9495876 [TBL] [Abstract][Full Text] [Related]
16. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Lefer AM; Lefer DJ Cardiovasc Res; 1996 Oct; 32(4):743-51. PubMed ID: 8915192 [TBL] [Abstract][Full Text] [Related]
17. Emerging treatment options for venous ulceration in today's wound care practice. Kistner RL; Shafritz R; Stark KR; Warriner RA Ostomy Wound Manage; 2010 Apr; 56(4):E1-11. PubMed ID: 20424289 [TBL] [Abstract][Full Text] [Related]